Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
Cancer is associated with single or multiple gene defects. Recently, much research has focused on incorporating genetic materials as one of the means to treat various types of carcinomas. RNA interference (RNAi) conveys an alternative genetic approach for cancer patients, especially when conventiona...
Main Authors: | Dima Hattab, Amirah Mohd Gazzali, Athirah Bakhtiar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/7/1009 |
Similar Items
-
Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements
by: Dima Hattab, et al.
Published: (2020-09-01) -
siRNA Delivery Technology for Cancer Therapy: Promise and Challenges
by: Fateme Karimi Dermani, et al.
Published: (2019-03-01) -
Cyclic Peptide-Capped Gold Nanoparticles for Enhanced siRNA Delivery
by: Amir Nasrolahi Shirazi, et al.
Published: (2014-08-01) -
Research progress of siRNA in anti-influenza viral infection
by: Han Li
Published: (2018-06-01) -
Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles
by: Abhijeet Lokras, et al.
Published: (2021-01-01)